Purdue Pharma L.P.:企業のM&A・事業提携・投資動向

◆英語タイトル:Purdue Pharma L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2113
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:89
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Purdue Pharma L.P. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Purdue Pharma L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Purdue Pharma L.P. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Purdue Pharma L.P.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Purdue Pharma L.P.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Purdue Pharma L.P.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Purdue Pharma L.P. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Purdue Pharma L.P.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Purdue Pharma L.P.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 11
Corporate Venturing – Overview 11
Corporate Venturing – Deal reports 12
PARTNERSHIP 26
Partnership – Overview 26
Partnership – Deal reports 27
DIVESTMENTS 71
Divestments – Overview 71
Divestments – Deal reports 72
APPENDIX 79
Contact Us 79
About MarketLine Financial Deals Database 79
Deal Definition and Methodology 81
About MarketLine 88

List of Tables
Table 1: Purdue Pharma L.P. M&A volume and value trend (2014-YTD2018)
Table 2: Purdue Pharma L.P. M&A activity by geography (2014-YTD2018)
Table 3: Purdue Pharma L.P. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Purdue Pharma L.P. corporate venturing by geography (2014-YTD2018)
Table 5: Purdue Pharma L.P. partnership volume and value trend (2014-YTD2018)
Table 6: Purdue Pharma L.P. partnership trend by key deal type (2014-YTD2018)
Table 7: Purdue Pharma L.P. divestments volume and value trend (2014-YTD2018)
Table 8: Purdue Pharma L.P. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Purdue Pharma L.P. M&A volume and value trend (2014-YTD2018)
Figure 2: Purdue Pharma L.P. M&A activity by geography (2014-YTD2018)
Figure 3: Purdue Pharma L.P. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Purdue Pharma L.P. corporate venturing by geography (2014-YTD2018)
Figure 5: Purdue Pharma L.P. partnership volume and value trend (2014-YTD2018)
Figure 6: Purdue Pharma L.P. partnership trend by key deal type (2014-YTD2018)
Figure 7: Purdue Pharma L.P. divestments volume and value trend (2014-YTD2018)
Figure 8: Purdue Pharma L.P. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Purdue Pharma L.P.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Collagen Matrix Inc:製品パイプライン分析
    Summary Collagen Matrix Inc (Collagen Matrix) is a medical equipment company that designs, manufactures and markets collagen and mineral-based finished medical devices and bio materials. The company’s products include block bone graft matrix, putty bone graft matrix, bone graft matrix, collagen memb …
  • Exelon Corp:企業の発電所・SWOT分析2018
    Exelon Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Great Eastern Holdings Limited (G07):企業の財務・戦略的SWOT分析
    Great Eastern Holdings Limited (G07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lennox International Inc (LII):企業の財務・戦略的SWOT分析
    Lennox International Inc (LII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Kirin Holdings Co Ltd:戦略・SWOT・企業財務分析
    Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eurofins Scientific SE:企業の戦略・SWOT・財務分析
    Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report Summary Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Akamai Technologies Inc (AKAM):企業の財務・戦略的SWOT分析
    Akamai Technologies Inc (AKAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • American Electric Power Company, Inc.:企業の戦略・SWOT・財務情報
    American Electric Power Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Electric Power Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Securitas AB:戦略・SWOT・企業財務分析
    Securitas AB - Strategy, SWOT and Corporate Finance Report Summary Securitas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • GS Yuasa Corporation (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corporation (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nanolek:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanolek is a drug development company that offers production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines, drugs for treatment of leukemias, breast cancer, brain cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and ot …
  • Ziehm Imaging GmbH-医療機器分野:企業M&A・提携分析
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that specializes in the development, production and global marketing of mobile X-ray based imaging solutions. The company's product portfolio includes ziehm vision RFD 3D, ziehm vision RFD hybrid edition, ziehm vision RFD, ziehm …
  • Profectus BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Profectus BioSciences Inc (Profectus) is a clinical-stage vaccine development company that designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company's products include genevax therapeutic vaccines, vesiculova …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Diploma PLC (DPLM):企業の財務・戦略的SWOT分析
    Summary Diploma PLC (Diploma) is a supplier of technical products and services. The company operates through its business such as life sciences, seals and controls. Its life sciences segment supplies instrumentation, consumables, and related services to the healthcare and environmental industries. D …
  • Consolidated Construction Consortium Limited:企業の戦略・SWOT・財務情報
    Consolidated Construction Consortium Limited - Strategy, SWOT and Corporate Finance Report Summary Consolidated Construction Consortium Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Stereotaxis Inc (STXS)-製薬・医療分野:企業M&A・提携分析
    Summary Stereotaxis Inc (Stereotaxis) is a healthcare technology company that designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch Solution is an advanced remote robotic navigation system for …
  • SRF Ltd (SRF):企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Lidds AB (LIDDS):企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Romaero SA Bucuresti:企業の戦略・SWOT・財務分析
    Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report Summary Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆